Economic TimesNovartis says Signifor LAR drug helps control acromegaly diseaseReutersZURICH (Reuters) – Swiss drugmaker Novartis said on Monday a final-stage trial of its Signifor LAR therapy allowed for greater disease control in patients with the endocrine disorder acromegaly than existing therapies. Acromegaly is caused by a benign …Novartis drug Signifor® LAR shows superior efficacy in acromegaly patients not …PR Newswire (press release)all 6 news articles …Read Full Story
Novartis says Signifor LAR drug helps control acromegaly disease - Reuters
Real Estate of Cebu
